{"id":27644,"date":"2014-12-01T08:31:15","date_gmt":"2014-12-01T08:31:15","guid":{"rendered":"http:\/\/i-base.info\/htb\/?p=27644"},"modified":"2014-12-01T10:01:47","modified_gmt":"2014-12-01T10:01:47","slug":"12th-glasgow-congress-on-hiv-therapy-2-6-november-2014-glasgow","status":"publish","type":"post","link":"https:\/\/i-base.info\/htb\/27644","title":{"rendered":"12th Glasgow Congress on HIV Therapy, 2-6 November 2014, Glasgow"},"content":{"rendered":"<p><strong>This two-yearly meeting always provides a good setting for important European research and has the advantage of having a single-track programme with no overlapping sessions.<\/strong><\/p>\n<p>Abstract are available on the conference website.<\/p>\n<p><a href=\"http:\/\/hivglasgow.org\/abstracts\">http:\/\/hivglasgow.org\/abstracts<\/a><\/p>\n<p>Many of the oral presentations are also available as webcasts:<\/p>\n<p><a href=\"http:\/\/hivglasgow.org\/scientificprogramme\">http:\/\/hivglasgow.org\/scientificprogramme<\/a><\/p>\n<p>Reports in this issue of HTB are:<\/p>\n<ul>\n<li><a href=\"https:\/\/i-base.info\/htb\/27642\">Savings to the NHS predicted from switching to generic antiretrovirals<\/a><\/li>\n<li><a href=\"https:\/\/i-base.info\/htb\/27640\">Lower than standard doses of efavirenz effective in two studies<\/a><\/li>\n<li><a href=\"https:\/\/i-base.info\/htb\/27638\">Should tenofovir be dosed at 200-250 mg\/day with protease inhibitors?<\/a><\/li>\n<li><a href=\"https:\/\/i-base.info\/htb\/27636\">3TC inferior to FTC in Dutch cohort but interchangeable in other studies<\/a><\/li>\n<li><a href=\"https:\/\/i-base.info\/htb\/27632\">Suicide not associated with efavirenz use in D:A:D cohort<\/a><\/li>\n<li><a href=\"https:\/\/i-base.info\/htb\/27627\">Gender differences in use of cardiovascular disease-related interventions: D:A:D study<\/a><\/li>\n<li><a href=\"https:\/\/i-base.info\/htb\/27624\">Efavirenz decreases exposure to hormonal contraceptive implant<\/a><\/li>\n<li><a href=\"https:\/\/i-base.info\/htb\/27620\">Increased risk of ART-related hepatotoxicity in HIV positive pregnant women<\/a><\/li>\n<li><a href=\"https:\/\/i-base.info\/htb\/27618\">Darunavir pharmacokinetics in pregnancy and postpartum<\/a><\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>This two-yearly meeting always provides a good setting for important European research and has the advantage of having a single-track programme with no overlapping sessions. Abstract are available on the conference website. http:\/\/hivglasgow.org\/abstracts Many of the oral presentations are also &hellip;<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[12,198],"class_list":["post-27644","post","type-post","status-publish","format-standard","hentry","category-conference-reports","tag-conference-index","tag-hiv-12-glasgow-2014"],"_links":{"self":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/27644","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/comments?post=27644"}],"version-history":[{"count":0,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/27644\/revisions"}],"wp:attachment":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/media?parent=27644"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/categories?post=27644"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/tags?post=27644"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}